Stockscreener 앱 받기
63.46
1.47%
0.92
시장 영업 전:
63.60
0.14
+0.22%
전일 마감가:
$62.54
열려 있는:
$63.38
하루 거래량:
1.94M
Relative Volume:
0.81
시가총액:
$9.88B
수익:
$1.17B
순이익/손실:
$150.71M
주가수익비율:
67.51
EPS:
0.94
순현금흐름:
$245.03M
1주 성능:
+7.07%
1개월 성능:
+19.40%
6개월 성능:
+33.57%
1년 성능:
-9.81%
1일 변동 폭
$62.63
$64.94
1주일 범위
$58.78
$64.94
52주 변동 폭
$46.01
$80.80
바이오-테크네 Stock (TECH) Company Profile
명칭
Bio Techne Corp
전화
(612) 379-8854
주소
614 MCKINLEY PL N E, MINNEAPOLIS, MN
TECH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
63.46 | 9.74B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.27 | 107.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
474.00 | 64.39B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
579.34 | 61.13B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
834.75 | 52.30B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.31 | 35.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
바이오-테크네 Stock (TECH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-08-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-07-22 | 재개 | Stephens | Overweight |
| 2025-07-09 | 개시 | TD Cowen | Buy |
| 2025-05-30 | 개시 | Wells Fargo | Overweight |
| 2025-04-09 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-02-08 | 개시 | Scotiabank | Sector Outperform |
| 2024-02-02 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-12-07 | 개시 | UBS | Buy |
| 2023-08-28 | 개시 | William Blair | Outperform |
| 2023-01-10 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | 업그레이드 | Stifel | Hold → Buy |
| 2021-01-25 | 재확인 | The Benchmark Company | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-07-15 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-05-14 | 개시 | The Benchmark Company | Buy |
| 2020-01-08 | 재개 | Stephens | Overweight |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-07-02 | 업그레이드 | Janney | Neutral → Buy |
| 2019-01-14 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2018-10-17 | 개시 | Goldman | Neutral |
| 2018-06-15 | 개시 | Argus | Buy |
| 2017-07-13 | 개시 | Wells Fargo | Market Perform |
| 2017-02-09 | 개시 | Citigroup | Buy |
| 2017-01-18 | 개시 | Deutsche Bank | Buy |
| 2016-11-10 | 재개 | Leerink Partners | Outperform |
| 2015-01-21 | 재확인 | Robert W. Baird | Outperform |
| 2013-09-20 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
모두보기
바이오-테크네 주식(TECH)의 최신 뉴스
How to forecast Bio Techne Corporation trends using time seriesJuly 2025 Price Swings & Verified Momentum Stock Watchlist - newser.com
How Bio Techne Corporation stock performs in rate cut cyclesJuly 2025 Trade Ideas & Real-Time Volume Trigger Notifications - newser.com
Bio-Techne Corp. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains - 富途牛牛
Can Bio Techne Corporation (TE1) stock sustain breakout momentumQuarterly Market Summary & Weekly Chart Analysis and Trade Guides - newser.com
What to do if you’re stuck in Bio Techne CorporationPrice Action & Expert Curated Trade Ideas - newser.com
Comparing Bio Techne Corporation in custom built stock radars2025 Market WrapUp & Free Real-Time Market Sentiment Alerts - newser.com
Will Bio Techne Corporation (TE1) stock hit Wall Street targetsJuly 2025 EndofMonth & Trade Opportunity Analysis Reports - newser.com
Is Bio Techne Corporation (TE1) stock a top hedge fund pickPortfolio Performance Report & AI Forecast Swing Trade Picks - newser.com
Will Bio Techne Corporation price bounce be sustainableJuly 2025 Breakouts & Real-Time Volume Analysis - newser.com
Detecting price anomalies in Bio Techne Corporation with AIWeekly Profit Analysis & Community Verified Watchlist Alerts - newser.com
Assessing Bio-Techne Shares After a 20% Surge and New Therapeutics Collaboration in 2025 - Yahoo
Why analysts recommend Bio Techne Corporation (TE1) stock2025 Winners & Losers & Short-Term Swing Trade Alerts - nchmf.gov.vn
Aug Setups: What Wall Street predicts for Bio Techne Corporation stock priceJuly 2025 Action & Weekly Sector Rotation Insights - nchmf.gov.vn
Can Bio Techne Corporation stock maintain growth trajectoryPortfolio Update Report & Weekly Breakout Watchlists - nchmf.gov.vn
Targets Report: Why Bio Techne Corporation (TE1) stock trades below fair value2025 Market Sentiment & Pattern Based Trade Signal System - nchmf.gov.vn
Growth Review: What Wall Street predicts for Bio Techne Corporation stock priceJuly 2025 Setups & Stepwise Entry and Exit Trade Signals - nchmf.gov.vn
Smart tools for monitoring Bio Techne Corporation’s price actionJuly 2025 Selloffs & Verified High Yield Trade Plans - newser.com
What analysts say about Bio Techne Corporation TE1 stockMarket Liquidity Analysis & Stay Invested. Stay Smart. - earlytimes.in
Agenda | xMAP Connect Virtual - Labroots
Earnings Preview: What to Expect From Bio-Techne's Report - MSN
Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch
What to expect from Bio Techne Corporation in the next 30 daysTrade Entry Summary & Verified Short-Term Plans - newser.com
Will Bio Techne Corporation stock benefit from sector rotationMarket Risk Analysis & Reliable Price Action Trade Plans - newser.com
Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results - Investing News Network
Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents - Investing News Network
Visual analytics tools that track Bio Techne Corporation performancePortfolio Value Report & Stepwise Trade Execution Plans - newser.com
How To YieldBoost Bio-Techne To 9.7% Using Options - Nasdaq
Q1 FY2026 Results Nov 5, 2025 — Bio-Techne Hosts 8:00 a.m. CST Webcast; Replay Available thru Dec 5 - Stock Titan
Bio-Techne (TECH) Analyst Rating Update: TD Cowen Raises Price T - GuruFocus
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MSN
Earnings Preview: What To Expect From Bio-Techne's Report - Barchart.com
Is Bio Techne Corporation stock a contrarian buy2025 AllTime Highs & Free Daily Entry Point Trade Alerts - newser.com
KLP Kapitalforvaltning AS Decreases Stake in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp (TECH) Investor Outlook: Navigating Growth with a 13.65% Potential Upside - DirectorsTalk Interviews
Statistical indicators supporting Bio Techne Corporation’s strengthJuly 2025 Volume & Real-Time Stock Price Movement Reports - newser.com
Bio-Techne Corp. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
Legal Advantage Investments Inc. Acquires 5,000 Shares of Bio-Techne Corp $TECH - MarketBeat
Bio-Techne (FRA:TE1) Change In Inventory : €-17 Mil (TTM As of Jun. 2025) - GuruFocus
Bio-Techne Corp (1TECH.MI) insider ownership and holdings - Yahoo
Bio-Techne Corp. stock underperforms Friday when compared to competitors - MarketWatch
Bio-Techne CorpCommon Stock (NQ: - FinancialContent
ConMed adds Bio-Techne CEO to board of directors - Central New York Business Journal
Bio-Techne (TECH): Valuation Spotlight Following Expanded Oxford Nanopore Partnership and Growth Strategy Realignment - Yahoo Finance
Bio Techne Corporation stock daily chart insightsEarnings Growth Report & Smart Investment Allocation Insights - newser.com
Can Bio Techne Corporation recover in the next quarterWeekly Stock Summary & Verified Momentum Stock Alerts - newser.com
Will Bio Techne Corporation stock deliver shareholder valueJuly 2025 Momentum & Technical Pattern Based Signals - newser.com
Bio-Techne Corp (1TECH.MI) recent insider transactions - Yahoo
Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032 - Investing News Network
Bio-Techne (TECH) Expands Partnership with Oxford Nanopore Technologies - GuruFocus
Bio-techne expands genetic testing collaboration with Oxford Nanopore - Investing.com
Bio-Techne Corp. stock underperforms Tuesday when compared to competitors - MSN
바이오-테크네 (TECH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
바이오-테크네 주식 (TECH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Nusse Roeland | Director |
Aug 25 '25 |
Sale |
56.36 |
17,040 |
960,388 |
44,559 |
| BAUMGARTNER ROBERT V | Director |
Aug 25 '25 |
Option Exercise |
21.84 |
17,040 |
372,154 |
61,903 |
| BAUMGARTNER ROBERT V | Director |
Aug 25 '25 |
Sale |
56.21 |
17,040 |
957,818 |
44,863 |
2.32%
1.34%
자본화:
|
볼륨(24시간):